Associated Papers
Targeted therapy guided by circulating tumor DNA analysis in advanced gastrointestinal tumors.
Nakamura Y et al.
Nature Medicine, 2025
39284955 (PubMed )
Supplement: 41591_2024_3244_MOESM2_ESM.xlsx › Suppementary_Table_1
Validation of a Molecular Diagnostic Test for Circulating Tumor DNA by Next-Gen Sequencing.
Fernandez SV et al.
International Journal of Molecular Sciences, 2023
Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.
Hescheler DA et al.
Frontiers in Endocrinology, 2021
34630336 (PubMed )
Supplement: Table_1.xlsx › Tab2
Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.
Ross JS et al.
Cancer, 2018
29338072 (PubMed )
Supplement: CNCR-124-1358-s002.xlsx › Colon
A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC.
Schell MJ et al.
Nature Communications, 2016
27302369 (PubMed )
Supplement: ncomms11743-s3.xlsx › GCC_62CRC
Familial colorectal cancer type X syndrome: two distinct molecular entities?
Francisco I et al.
Familial Cancer, 2011
[Familial colorectal cancer type X: clinical, pathological and molecular characterization].
Ferreira S et al.
Acta Medica Portuguesa, 0
Select a paper to view details